Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2002
10/31/2002WO2002040045A3 Microspheres of pancreatic enzymes with high stability
10/31/2002WO2002022611A3 Caspase inhibitors and uses thereof
10/31/2002WO2002014499A3 Claudin polypeptides
10/31/2002WO2002004002A3 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
10/31/2002WO2001061356A9 Her-2 binding antagonists
10/31/2002WO2001059081A9 Methods for using 20893, a human protein kinase
10/31/2002WO2001044243A3 Novel heteroaryl-diazabicycloalkanes
10/31/2002WO2000062766A3 Uses of ppar-gamma agonists in neutrophil-induced diseases
10/31/2002US20020161262 Use treating various medical conditions, including pain
10/31/2002US20020161047 Method for preventing and treating visceral pain and gastrointestinal disorders
10/31/2002US20020161042 Nitric oxide donor composition and method for treatment of anal disorders
10/31/2002US20020161039 Crystalline choline ascorbate
10/31/2002US20020161038 Inosine 5'-monophosphate dehydrogenase (IMPDH); prodrug having functional group -CO-N(-R)-COO-, a carrier, and an immunosuppressant, anticancer agent, antiviral agent, or anti-vascular hyperproliferation agent
10/31/2002US20020161033 Substituted 1,5-dihydropyrrol-2-one derivatives active as NMDA receptor antagonists for treatment of states of pain
10/31/2002US20020161024 Administering 2-(piperidin-2,6-dion-3-yl),4-amino-isoindolin-1-one to treat an eye condition
10/31/2002US20020161019 For treatment of depression, anxiety, feeding disorders, headache, drug addiction, inflammatory disorders
10/31/2002US20020161010 Treatment of various disorders associated with enhanced activity of kinase p38-alpha and/or transforming growth factor beta; antiinflammatory agents
10/31/2002US20020161006 1,4-dihydropyridine compounds as bradykinin antagonists
10/31/2002US20020160999 Treatment of diseases or disorders of the central nervous system
10/31/2002US20020160997 Novel indole derivatives
10/31/2002US20020160987 Novel 4-dedimethylaminotetracycline derivatives
10/31/2002US20020160984 For example, 2,3-dihydro-1H-benz(de)isoquinolin-1-one; treating diabetes, cancer, radiosensitizing tumor cells, cardiovascular disorders, septic shock, inflammatory bowel disease, senescent cells
10/31/2002US20020160982 Modafinil compound and cyclodextrin mixtures
10/31/2002US20020160980 Method of treating hepatitis delta virus infection
10/31/2002US20020160962 Non-structural protein 3 (NS3), part of a hepatitis C virus protease necessary for polypeptide processing and viral replication; alpha-ketoamide compounds of given formula
10/31/2002US20020160955 Protein variants
10/31/2002US20020160494 Tendon-inducing compositions
10/31/2002US20020160481 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof
10/31/2002US20020160478 Short peptides which selectively modulate the activity of protein kinases
10/31/2002US20020160059 Treatment of urogenital disorders, menstrual cramps
10/31/2002US20020160052 Tissue graft composition comprising liver basement membrane; graft composition can be implanted to replace or induce repair of damaged or diseased tissues
10/31/2002US20020160044 Liver selective drug therapy
10/31/2002US20020160000 PD-1, a receptor for B7-4, and uses therefor
10/31/2002US20020159976 An isolated polynucleotide comprising a nucleotide sequence present in Lactobacillus rhamnosus strain HN001 that encodes a polypeptide having atleast one enzymetic activity; genetic engineering
10/31/2002US20020159973 Administering to the patient at least one statin (HMG-Coa-reductase inhibitor) in an amount effective to modulate MHC class II (Major Histocompability complex) or CD/40(antigen) expression in the patient
10/31/2002US20020159956 Providing a chewing gum, includes a gum center and a coating coverings, coating includes a drug designed to be delivered into systemic system of indivisual
10/31/2002US20020158255 Compounds of the general formula P1-L-P2; wherein "P1" is a pyrazinoylguanidine sodium channel blocker, "L" is a linking group, and "P2" is either (i) a pyrazinoylguanidine sodium channel blocker or (ii) a P2Y2 receptor agonist, are disclosed
10/31/2002DE10121217A1 6H-Oxazolo[4,5-e]indol-Derivate als nikotinische Acetylcholinrezeptor Liganden und/oder serotonerge Liganden 6H-oxazolo [4,5-e] indole derivatives as nicotinic acetylcholine receptor ligands and / or serotonergic ligands
10/31/2002DE10121215A1 Dihydro-imidazo[4,5-e]indol- und 7H-Pyrrolo[3,2-f]chinoxalin Derivate als nikotinische Acetylcholinrezeptor Liganden und/oder serotonerge Liganden Dihydro-imidazo [4,5-e] indole and 7H-pyrrolo [3,2-f] quinoxaline derivatives as nicotinic acetylcholine receptor ligands and / or serotonergic ligands
10/31/2002DE10120627A1 Verwendung von Phyllanthusbestandteilen zur Behandlung oder Prophylaxe von Infekten durch Hepatitis B-Viren Use of Phyllanthus for the treatment or prophylaxis of infections caused by hepatitis B viruses
10/31/2002CA2483507A1 Enzyme and snp marker for disease
10/31/2002CA2445740A1 Use of metals to treat inflammatory skin conditions
10/31/2002CA2445734A1 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue
10/31/2002CA2445729A1 Use of metals to treat mucosal membranes
10/31/2002CA2445255A1 Vhh single heavy chain antibody and a method for its preparation in a mammal
10/31/2002CA2445233A1 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002CA2445188A1 Arylindenopyridines with pde inhibiting activity
10/31/2002CA2445168A1 Human timp-1 antibodies
10/31/2002CA2444885A1 Methods and compositions for treating oral and esophageal lesions
10/31/2002CA2444675A1 Secreted proteins
10/31/2002CA2444595A1 Benzimidazolone derivatives
10/31/2002CA2444563A1 Tissue fibrosis inhibitors
10/31/2002CA2444370A1 Use of radical scavenging compounds for treatment and prevention of no-dependent microcirculation disorders
10/31/2002CA2444235A1 New polynucleotides and polypeptides of the ifn.alpha.-17 gene
10/31/2002CA2444095A1 Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/31/2002CA2443946A1 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
10/31/2002CA2443944A1 Agent for prophylaxis or treatment of inflammatory diseases in mucosa of oral cavity and the like
10/31/2002CA2443935A1 Ppar-alpha-gamma ligands or agonists for the treatment of inflammation
10/31/2002CA2443605A1 Process for purifying 6-methoxy omeprazole
10/31/2002CA2443600A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002CA2443587A1 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/31/2002CA2443373A1 New polynucleotides and polypeptides of the erythropoietin gene
10/30/2002EP1252891A1 Remedies or preventives for liver diseases containing diaminotrifluoromethylpyridine derivatives
10/30/2002EP1252890A1 Remedies or preventives for digestive diseases containing diaminotrifluoromethylpyridine derivatives
10/30/2002EP1252333A2 Methods and materials relating to cd84-like polypeptides and polynucleotides
10/30/2002EP1252293A1 Liver tissue source
10/30/2002EP1252189A2 Novel human nucleic acid molecules and polypeptides encoding cation channels
10/30/2002EP1252188A2 G-protein coupled receptors
10/30/2002EP1252180A2 Virulence genes, proteins, and their use
10/30/2002EP1252178A1 Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease
10/30/2002EP1252163A2 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
10/30/2002EP1252161A1 Pyrrolo-isoquinoline and tetrahydropyrrolo-isoquinoline derivatives and their use as mediators of the 5-ht7 receptor
10/30/2002EP1252158A1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes
10/30/2002EP1252157A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
10/30/2002EP1252150A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
10/30/2002EP1252144A1 Substituted glutarimides and use thereof il-12 production inhibitors
10/30/2002EP1252143A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives
10/30/2002EP1252133A2 Pharmaceutical compounds
10/30/2002EP1251869A2 Compositions and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compositions
10/30/2002EP1251865A1 Cyclic peptides as potent and selective melanocortin-4 receptor antagonists
10/30/2002EP1251848A1 Gyrase inhibitors and uses thereof
10/30/2002EP1251844A2 Laxative preparation containing l-arginine
10/30/2002EP1251839A2 Use of cox-2 inhibitors for the treatment of constipation
10/30/2002EP1251829A1 Electrospun pharmaceutical compositions
10/30/2002EP1251824A2 Methods of using a beverage composition for treating dental erosion
10/30/2002EP1251750A1 Improved pediatric formula and methods for providing nutrition and improving tolerance
10/30/2002EP1251747A2 Pet food composition for treating helicobacter species in pets
10/30/2002EP1251739A2 Poly(dipeptide) as a drug carrier
10/30/2002EP1017412A4 Genes coding proteins for early liver development and their use in diagnosing and treating liver disease
10/30/2002EP0991410B1 Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
10/30/2002EP0831835B1 Treating anorexia
10/30/2002EP0793660B1 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
10/30/2002EP0726911B1 Treatment of hematologic disorders with a igf-1/igfbp-3 complex
10/30/2002CN1377424A Methods of reparing tandemly repeated DNA sequences and extending cell life-span using nuclear transfer
10/30/2002CN1377365A Eplerenone crystalline form exhibiting enhanced dissolution rate
10/30/2002CN1377356A Certain alkylene diamine-substituted heterocycles
10/30/2002CN1377355A Amino substituted pyrazolo [1,5-2]-1,5-pyrimidines and pyrazolo [1,5-2]-1,3, 5-triazines
10/30/2002CN1377352A Selective antagonists of A28 adenosine receptors
10/30/2002CN1377348A 4,5-diaryloxazole compounds with prostaglandin 12 (PG12) agonistic activity
10/30/2002CN1377347A 药学活性磺酰胺衍生物 Pharmaceutically active sulfonamide derivatives
1 ... 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 ... 1258